Inhibition of proliferation by PERK regulates mammary acinar morphogenesis and tumor formation

Sharon J Sequeira1, Aparna C Ranganathan, Alejandro P Adam

  • 1Department of Biomedical Sciences, School of Public Health and Center for Excellence in Cancer Genomics, University at Albany, State University of New York, Rensselaer, New York, United States of America.

Plos One
|July 20, 2007
PubMed

Insights

Endoplasmic reticulum (ER) stress kinase PERK limits mammary cell proliferation and prevents tumor formation by responding to cell adhesion signals. Its deficiency leads to hyperproliferation and architectural defects during mammary gland development.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Endoplasmic reticulum (ER) stress signaling, mediated by ER kinase PERK, regulates cell growth via eIF2alpha phosphorylation, impacting cell cycle arrest and apoptosis.
  • Cell adhesion perturbations can also trigger these growth-limiting responses, suggesting a link between adhesion and ER stress pathways.

Purpose of the Study:

  • To investigate the hypothesis that adhesion-dependent regulation of PERK signaling dictates cell fate.
  • To elucidate the role of PERK in mammary acini development and mammary tumor formation.

Main Methods:

  • Utilized a model of mammary acini development in 3D Matrigel culture.
  • Employed dominant-negative PERK mutants (PERK-DeltaC, PERK-K618A) to inhibit endogenous PERK signaling.
  • Assessed cell proliferation, apoptosis, acini architecture, and gene expression.
  • Evaluated tumorigenicity of MCF10A cells in vivo via orthotopic implantation.

Main Results:

  • Loss of cell adhesion induced PERK-dependent eIF2alpha phosphorylation and upregulated ATF4 and GADD153.
  • Inhibition of PERK signaling resulted in hyper-proliferative, architecturally abnormal acini without affecting apoptosis.
  • PERK inhibition correlated with increased translation initiation, Ki67 staining, and upregulation of Laminin-5, ErbB1, and ErbB2.
  • MCF10A cells expressing PERK-DeltaC were tumorigenic in vivo, unlike vector controls.

Conclusions:

  • The PERK pathway is responsive to adhesion-regulated signals and is crucial for proper mammary acinar morphogenesis.
  • PERK signaling is essential for limiting mammary epithelial cell proliferation and preventing mammary tumor formation.
  • Deficiencies in PERK signaling may contribute to mammary epithelial hyperproliferation and increase breast cancer risk.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...